HIV-1 reverse transcriptase inhibitors

Author： Krawczyk Sören Hilgeroth Andreas

ISSN： 2195-2175

Source： PHARMAKON, Vol.2, Iss.4, 2014-07, pp. : 270-276

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M. Morrison I.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite

The Role of Non-Nucleoside Reverse Transcriptase Inhibitors in Children with HIV-1 Infection

By Maddocks S. Dwyer D.

Pediatric Drugs, Vol. 3, Iss. 9, 2001-01 ,pp. : 681-702

Adis International

Access to resources Recommend Favorite

Inhibitors of HIV-1 Reverse Transcriptase and Integrase: Classical and Emerging Therapeutical Approaches

Current Pharmaceutical Design, Vol. 8, Iss. 8, 2002-04 ,pp. : 595-614

Bentham Science Publishers

Access to resources Recommend Favorite

Developing Novel Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors: Beyond the Butterfly

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-05 ,pp. : 1857-1865

Bentham Science Publishers

Access to resources Recommend Favorite